![Erin Mitchell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erin Mitchell
Corporate Officer/Principal at DNAtrix, Inc.
Erin Mitchell active positions
Companies | Position | Start | End |
---|---|---|---|
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Career history of Erin Mitchell
Former positions of Erin Mitchell
Companies | Position | Start | End |
---|---|---|---|
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Training of Erin Mitchell
McMaster University | Undergraduate Degree |
University of Toronto | Graduate Degree |
University of Cambridge | Doctorate Degree |
Statistics
International
United States | 3 |
Canada | 3 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 4 |
Electronic Technology | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Technology |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Erin Mitchell
- Experience